“Risk Assessment of Cyclophosphamide and Mycophenolate Mofetil after Induction Treatment of Lupus Nephritis: A Single Center Quasi-Experimental Study” (2023) Chattagram Maa-O-Shishu Hospital Medical College Journal, 22(1), pp. 28–32. doi:10.3329/cmoshmcj.v22i1.67831.